MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical ...
Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...
Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...
No matter your personal taste, you’re sure to find spaces that delight and move you. By T Magazine Low-to-the-ground styles to hold in high esteem, no matter the price point. By Tom Delavan A leading ...
The authors sought to understand the differential impact of payer-led community-based care management approaches on stakeholder-oriented outcomes for publicly insured adults with multiple chronic ...
Two text message or phone reminders were more effective in reducing missed primary care appointments than a single reminder, particularly in patients at high risk of missing appointments. Objectives: ...
Data collection is sometimes performed without considering the effect poorly collected data has in the strength of statistical conclusions. When researchers properly design an experiment, they are ...
We have already seen that varying two factors simultaneously provides an effective experimental design for exploring the main (average) effects and interactions of the factors 1. However, in practice, ...
Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback